Frontlight ResearchEarly access
Trial site
The Center for Cancer and Blood Disorders
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers2 trials
- Colorectal cancer2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Prostate cancer2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- and 5 more
- Phase
- Phase 1/22 trials
- Phase 22 trials
- Phase 2/31 trial
- Phase 31 trial
- Status
- Recruiting5 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Tempus AI2 trials
- Allogene Therapeutics1 trial
- Bayer1 trial
- Eikon Therapeutics1 trial
- Kartos Therapeutics, Inc.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Acute myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Melanoma1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026